Gastrointestinal stromal tumors (GISTs) are the major gastrointestinalmesenchymal tumors with a variable malignancy ranging froma curable disorder to highly malignant sarcomas.Metastasis and recurrence are the main causes of death in GIST patients. To further explore the mechanism of metastasis and to more accurately estimate the recurrence risk of GISTs after surgery, the clinical significance and functional role of collagen triple helix repeat containing-1 (CTHRC1) in GIST were investigated. We found that CTHRC1 expression was gradually elevated as the risk grade of NIH classification increased, and was closely correlated with disease-free survival and overall survival in 412 GIST patients. In vitro experiments showed that recombinant CTHRC1 protein promoted the migration and invasion capacities of primary GIST cells. A luciferase reporter assay and pull down assay demonstrated that recombinant CTHRC1 protein activated noncanonical Wnt/PCP-Rho signaling but inhibited canonical Wnt signaling. The pro-motility effect of CTHRC1 on GIST cells was reversed by using a Wnt5a neutralizing antibody and inhibitors of Rac1 or ROCK. Taken together, these data indicate that CTHRC1 may serve as a new predictor of recurrence risk and prognosis in postoperative GIST patients and may play an important role in facilitating GIST progression. Furthermore, CTHRC1 promotes GIST cell migration and invasion by activating Wnt/PCP-Rho signaling, suggesting that the CTHRC1-Wnt/ PCP-Rho axis may be a new therapeutic target for interventions against GIST invasion and metastasis. © 2014 Neoplasia Press, Inc. All rights reserved.
M.-Z., M., C., Z., X.-M., Y., Z.-Z., Z., H., M., W.-M., Z., … Z.-G., Z. (2014). CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling. Neoplasia (United States), 16(3), 265–278. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L373076726